Ingo Hilgendorf

7.1k total citations · 4 hit papers
90 papers, 3.7k citations indexed

About

Ingo Hilgendorf is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Ingo Hilgendorf has authored 90 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 30 papers in Cardiology and Cardiovascular Medicine and 21 papers in Surgery. Recurrent topics in Ingo Hilgendorf's work include Atherosclerosis and Cardiovascular Diseases (17 papers), Immune cells in cancer (16 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). Ingo Hilgendorf is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (17 papers), Immune cells in cancer (16 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). Ingo Hilgendorf collaborates with scholars based in Germany, United States and Austria. Ingo Hilgendorf's co-authors include Filip K. Świrski, Clinton S. Robbins, Matthias Nahrendorf, Yoshiko Iwamoto, Ralph Weissleder, Andreas Zirlik, Louisa M.S. Gerhardt, Peter Libby, Georg F. Weber and Igor Theurl and has published in prestigious journals such as Science, Circulation and Nature Medicine.

In The Last Decade

Ingo Hilgendorf

80 papers receiving 3.7k citations

Hit Papers

4 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

2013 779 citations Clinton S. Robbins, Ingo Hilgendorf et al. profile →
Ly-6C ^high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium

2014 439 citations Ingo Hilgendorf, Yoshiko Iwamoto et al. Circulation Research profile →
Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry

2018 381 citations Holger Winkels, Erik Ehinger et al. Circulation Research profile →
Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities

2024 47 citations Ingo Hilgendorf et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingo Hilgendorf Germany	28	2.1k	1.2k	674	662	466	90	3.7k
Dennis Wolf Germany	31	1.9k 0.9×	1.2k 1.0×	428 0.6×	681 1.0×	373 0.8×	102	3.3k
Yvonne Döring Germany	33	2.4k 1.2×	1.3k 1.0×	427 0.6×	574 0.9×	462 1.0×	85	4.0k
Norbert Gerdes Germany	31	2.2k 1.0×	1.2k 1.0×	568 0.8×	911 1.4×	618 1.3×	74	4.3k
Peter Kanellakis Australia	35	1.7k 0.8×	972 0.8×	582 0.9×	580 0.9×	586 1.3×	58	3.3k
Saskia C.A. de Jager Netherlands	35	1.5k 0.7×	1.5k 1.2×	778 1.2×	487 0.7×	667 1.4×	129	4.0k
Coleen A. McNamara United States	42	2.0k 1.0×	2.2k 1.8×	777 1.2×	787 1.2×	794 1.7×	114	5.3k
José Vilar France	38	1.2k 0.6×	2.1k 1.7×	1.0k 1.5×	318 0.5×	540 1.2×	89	4.3k
Robert M. Clancy United States	40	1.8k 0.9×	976 0.8×	923 1.4×	267 0.4×	405 0.9×	117	5.3k
José J. Fuster Spain	31	882 0.4×	1.6k 1.3×	927 1.4×	798 1.2×	440 0.9×	65	4.7k
Philipp J. Hohensinner Austria	30	925 0.4×	1.4k 1.1×	444 0.7×	391 0.6×	386 0.8×	76	3.1k

Countries citing papers authored by Ingo Hilgendorf

Since Specialization

Citations

This map shows the geographic impact of Ingo Hilgendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Hilgendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Hilgendorf more than expected).

Fields of papers citing papers by Ingo Hilgendorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Hilgendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Hilgendorf. The network helps show where Ingo Hilgendorf may publish in the future.

Co-authorship network of co-authors of Ingo Hilgendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Hilgendorf. A scholar is included among the top collaborators of Ingo Hilgendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Hilgendorf. Ingo Hilgendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lindner, Diana, Dennis Wolf, Stefan Tholen, et al.. (2025). Experimental evidence on colchicine's mode of action in human carotid artery plaques. Atherosclerosis. 406. 119239–119239. 2 indexed citations

Chan, Andy, Zafar Iqbal, Julieta Aprea, et al.. (2025). Spatiotemporal dynamics of the cardioimmune niche during lesion repair. Nature Cardiovascular Research. 4(11). 1550–1572.

Bacmeister, Lucas, Alexander Maier, Susanne Weber, et al.. (2025). Longitudinal Assessment of Subclinical Arterial Inflammation in Patients Receiving Immune Checkpoint Inhibitors by Sequential [ ¹⁸ F]FDG PET Scans. Circulation Cardiovascular Imaging. 18(2). e016851–e016851. 2 indexed citations

Mühlen, Constantin von zur, Timo Heidt, Alexander Supady, et al.. (2024). One-year outcome of robotical vs. manual percutaneous coronary intervention. Clinical Research in Cardiology. 114(8). 1000–1007. 5 indexed citations

Bacmeister, Lucas, Ersin Çavuş, Sebastian Bohnen, et al.. (2024). Serum Concentrations of Matrix Metalloproteinase‐1 and Procollagen Type I Carboxy Terminal Propeptide Discriminate Infarct‐Like Myocarditis and Non−ST‐Segment−Elevation Myocardial Infarction. Journal of the American Heart Association. 13(14). e034194–e034194.

Horstmann, Hauke, Rémi Peyronnet, Dietmar Pfeifer, et al.. (2024). Nonpreferential but Detrimental Accumulation of Macrophages With Clonal Hematopoiesis-Driver Mutations in Cardiovascular Tissues—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). 690–697. 4 indexed citations

Stoffers, Bastian, Lucas Bacmeister, Timoteo Marchini, et al.. (2023). GPR15-mediated T cell recruitment during acute viral myocarditis facilitated virus elimination and improved outcome. Nature Cardiovascular Research. 3(1). 76–93. 1 indexed citations

Hilgendorf, Ingo, Dennis Wolf, Jonathan Rilinger, et al.. (2023). Comparing balloon-expandable and self-expanding transfemoral transcatheter aortic valve replacement based on subgroups in Germany 2019/2020. Clinical Research in Cardiology. 113(1). 168–176. 5 indexed citations

Härdtner, Carmen, Maximilian Mauler, Bianca Dufner, et al.. (2022). Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury. Basic Research in Cardiology. 117(1). 61–61. 8 indexed citations

10.

Guillamat‐Prats, Raquel, Abhishek Derle, Carmen Härdtner, et al.. (2022). GPR55 in B cells limits atherosclerosis development and regulates plasma cell maturation. Nature Cardiovascular Research. 1(11). 1056–1071. 16 indexed citations

11.

Härdtner, Carmen, et al.. (2022). Everolimus-Loaded Reconstituted High-Density Lipoprotein Prepared by a Novel Dual Centrifugation Approach for Anti-Atherosclerotic Therapy. International Journal of Nanomedicine. Volume 17. 5081–5097. 4 indexed citations

12.

Reichardt, Wilfried, Beat A. Kaufmann, Dominik von Elverfeldt, et al.. (2021). P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction. Cells. 10(12). 3414–3414. 5 indexed citations

13.

Olivier, Christoph B., Nathaly Anto-Michel, Ingo Hilgendorf, et al.. (2021). Platelet Bone Morphogenetic Protein-4 Mediates Vascular Inflammation and Neointima Formation after Arterial Injury. Cells. 10(8). 2027–2027. 14 indexed citations

14.

Dufner, Bianca, Natalie Hoppe, Timo Heidt, et al.. (2021). Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe mice. Molecular Metabolism. 53. 101250–101250. 21 indexed citations

15.

Kessler, Thorsten, Tobias Graf, Ingo Hilgendorf, et al.. (2020). Hospital admissions with acute coronary syndromes during the COVID-19 pandemic in German cardiac care units. Cardiovascular Research. 116(11). 1800–1801. 8 indexed citations

16.

Winkels, Holger, Erik Ehinger, Melanie Vassallo, et al.. (2018). Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry. Circulation Research. 122(12). 1675–1688. 381 indexed citations breakdown →

17.

Heidt, Timo, Jan‐Bernd Hövener, Irene Neudorfer, et al.. (2016). Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging. Scientific Reports. 6(1). 25044–25044. 21 indexed citations

18.

Willecke, Florian, Nathaly Anto Michel, Ingo Hilgendorf, et al.. (2016). Abstract 18410: The Role of CD40 in Endothelial and Smooth Muscle Cells in Atherosclerosis. Circulation. 134. 1 indexed citations

19.

Rauch, Philipp J., Aleksey Chudnovskiy, Clinton S. Robbins, et al.. (2012). Innate Response Activator B Cells Protect Against Microbial Sepsis. Science. 335(6068). 597–601. 314 indexed citations

20.

Wolf, Dennis, Ingo Hilgendorf, Peter Stachon, et al.. (2011). Abstract 15272: Genetic Deficiency of CD40L Attenuates Diet-Induced Adipose Tissue Inflammation - but Does Not Protect From Insulin Resistance and Hepatic Steatosis in Mice. Circulation. 124.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact